GTR Home > Tests > Search results - C9orf72[gene]

Apply filters

Showing tests for all 1651 conditions

Compare labs

Your search term can be found in tests with a total of 1651 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for 203228[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 33 tests for 1651 conditions in 20 labs

CAmyotrophic lateral sclerosis with frontotemporal dementia

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

CAmyotrophic Lateral Sclerosis and Frontotemporal Dementia NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (16)
Total targets (21)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CC9orf72

Test targets
Methods
  • T Targeted variant analysis

CAmyotrophic Lateral Sclerosis Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)
Total targets (6)

CDementia all Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (32)
Total targets (21)

CFrontotemporal Dementia (FTD) Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (29)
Total targets (18)

CAmyotrophic Lateral Sclerosis (ALS) Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (29)
Total targets (30)

CHereditary Spastic Paraplegias (HSP) and differential diagnoses Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (147)
Total targets (133)

CC9orf72

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CC9orf72-RELATED NEURODEGENERATIVE DISEASE

Lab: Center for Human Genetics, Inc Cambridge, Massachusetts, United States
Test targets
Methods
  • T Targeted variant analysis

CComplete ALS Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States

CC9orf72 DNA Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • T Targeted variant analysis

CFrontotemporal Dementia Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States

CC9ORF72 (FTD) DNA Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • T Targeted variant analysis

CC9orf72. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain

CAmyotrophic Lateral Sclerosis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (47)
Total targets (24)

Showing 1 to 20 of 33 tests for 1651 conditions in 20 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.